scholarly journals AGE RELATED MACULAR DEGENERATION (ARMD) CLINICAL PROFILE AND MANAGEMENT

Author(s):  
Sanjay Thokare

Age Related Macular Degeneration (ARMD) next to cataract is the leading cause  visual loss in elderly. My study is to focus on cleanical profile of Age Related Macular Degeneration with effective Ayurveda management to increasing in average longitivity of an individual with advance in science and technology along with traditional  management.In research scenario it has been demonstrated that choroidal neovascular lesion of Age Related Macular Degeneration. Account for most of severe loss of vision attributed to this condition. My study tries to give additional option and contribution of Ayurveda to patient affected with Age Related Macular Degeneration. Macula is area which correspond to centre of vision. There are two types Dry and Wet ARMD based on appearance of  exudates and tiny haemorrhage in the macular area . in wet AMD treatment of Raktpitta should be followed. Though  description of macular degeneration is not described is classics . Gradual loss of vision in Timira we can assume this regenerative pathology as Prakopita Vatalakshana in Drushti Mandala .  Inn proper Tarpak Kapha result in weakening of function and death of life sensing cells of macula . In dry Age Related Macular Degeneration this cells breakdown slowly and result in loss of central vision . These can be stated Kaphavata Drushtijanya Timira . In case of wet AMD abnormal blood vessels start to grow under macula and eventually bleed . This explains Raktpitta Drushti . Management of Age Related Macular Degeneration should be done on the principle of Vatavyadhi with Rasayan Chikitsa . 

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Alessandro Arrigo ◽  
Emanuela Aragona ◽  
Ottavia Battaglia ◽  
Andrea Saladino ◽  
Alessia Amato ◽  
...  

AbstractOuter retinal tubulations (ORT) are a relatively new finding characterizing outer retinal atrophy. The main aim of the present study was to describe ORT development in advanced age-related macular degeneration (AMD) and to assess its relationship with disease’s severity. Patients with advanced AMD characterized either by macular neovascularization or geographic atrophy, showing signs of outer retinal disruption or retinal pigment epithelium atrophy on structural optical coherence tomography (OCT) at the inclusion examination were prospectively recruited. All the patients underwent complete ophthalmologic evaluation, structural OCT scans and fundus autofluorescence imaging. The planned follow-up was of 3-years. Main outcome measures were ORT prevalence, mechanism of ORT formation, mean time needed for complete ORT formation, best-corrected visual acuity (BCVA), definitely decreased autofluorescence (DDAF) area, questionably decreased autofluorescence (QDAF) area, retinal layer thickness, foveal sparing, number of intravitreal injections. We also assessed the possible role of external limiting membrane (ELM) and Müller cells in ORT pathogenesis. Seventy eyes (70 patients) were included; 43 showed dry AMD evolving to geographic atrophy, while 27 displayed the features of wet AMD. Baseline BCVA was 0.5 ± 0.5 LogMAR, decreasing to 0.9 ± 0.5 LogMAR at the 3-year follow-up (p < 0.01). We detected completely formed ORT in 26/70 eyes (37%), subdivided as follows: 20 eyes (77%) wet AMD and 6 eyes (23%) dry AMD (p < 0.01). ORT took 18 ± 8 months (range 3–35 months) to develop fully. We described the steps leading to ORT development, characterized by progressive involvement of, and damage to the photoreceptors, the ELM and the RPE. Eyes displaying ORT were associated with a smaller QDAF area, less retinal layers damage and lower rate of foveal sparing than eyes free of ORT (p < 0.01). We also described pigment accumulations simulating ORT, which were detected in 16/70 eyes (23%), associated with a greater loss of foveal sparing, increased DDAF area and smaller QDAF area at the 3-year follow-up (p < 0.01). In conclusion, this study provided a description of the steps leading to ORT development in AMD. ELM and Müller cells showed a role in ORT pathogenesis. Furthermore, we described a subtype of pigment hypertrophy mimicking ORT, evaluating its clinical utility.


2016 ◽  
Vol 38 (3) ◽  
pp. 233-237 ◽  
Author(s):  
Daiva Stanislovaitiene ◽  
Dalia Zaliuniene ◽  
Algimantas Krisciukaitis ◽  
Robertas Petrolis ◽  
Alina Smalinskiene ◽  
...  

2019 ◽  
Vol 20 (20) ◽  
pp. 5049 ◽  
Author(s):  
Ibuki ◽  
Shoda ◽  
Miwa ◽  
Ishida ◽  
Tsubota ◽  
...  

Background: Age-related macular degeneration (AMD) is the leading cause of blindness and can be classified into two types called atrophic AMD (dry AMD) and neovascular AMD (wet AMD). Dry AMD is characterized by cellular degeneration of the retinal pigment epithelium, choriocapillaris, and photoreceptors. Wet AMD is characterized by the invasion of abnormal vessels from the choroid. Although anti-vascular endothelial growth factor (VEGF) therapy has a potent therapeutic effect against the disease, there is a possibility of chorio-retinal atrophy and adverse systemic events due to long-term robust VEGF antagonism. We focused on hypoxia-inducible factor (HIF) regulation of VEGF transcription, and report the suppressive effects of HIF inhibition against ocular phenotypes in animal models. Many of the known HIF inhibitors are categorized as anti-cancer drugs, and their systemic side effects are cause for concern in clinical use. In this study, we explored food ingredients that have HIF inhibitory effects and verified their effects in an animal model of AMD. Methods: Food ingredients were screened using a luciferase assay. C57BL6/J mice were administered the Garcinia cambogia extract (Garcinia extract) and hydroxycitric acid (HCA). Choroidal neovascularization (CNV) was induced by laser irradiation. Results: Garcinia extract and HCA showed inhibitory effects on HIF in the luciferase assay. The laser CNV model mice showed significant reduction of CNV volume by administering Garcinia extract and HCA. Conclusions: Garcinia extract and HCA showed therapeutic effects in a murine AMD model.


Ophthalmology ◽  
2020 ◽  
Vol 127 (8) ◽  
pp. 1097-1104 ◽  
Author(s):  
Daniel Palanker ◽  
Yannick Le Mer ◽  
Saddek Mohand-Said ◽  
Mahiul Muqit ◽  
Jose A. Sahel

Sign in / Sign up

Export Citation Format

Share Document